Johnson & Johnson
I · Análisis con IA
En breve
J&J operates in two main areas: Innovative Medicine (prescription drugs for cancer, immunology, neuroscience, and other diseases) and MedTech (medical devices like surgical instruments, artificial joints, contact lenses under the ACUVUE brand, and robotic surgery systems) [Company Overview]. They sell to hospitals, doctors, pharmacies, and retailers worldwide [Company Overview].
Johnson & Johnson is a massive American healthcare company that makes both medicines (for cancer, immune diseases, etc.) and medical devices (surgical tools, contact lenses, artificial joints). With $96.4 billion in annual revenue and over 138,000 employees, it's one of the world's largest and most established healthcare firms [Company Overview].
Johnson & Johnson is in very strong financial shape with high profit margins and manageable debt.
Puntuación Sentinellis
10/10
Financieramente sana
Capitalización bursátil
$565,1B
Ingresos (12 meses)
$96,4B
Explicaciones
Cómo leemos estas cifras
Guías en lenguaje sencillo · sin cuenta
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LeerPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LeerAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LeerII · Noticias recientes
Qué movió el precio
1 noticia · ordenadas por relevancia
- Macro2026-04-16
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.7% – Time to Sell?
Ticker Report
Premium · gratis con cualquier cuenta
The Piotroski score of 3 out of 9 is concerning — this metric measures financial strength trends, and a low score suggests weakening fundamentals or operational efficiency compared to prior periods, though the specific drivers are not detailed in the data [Sentinellis calculation].
Riesgos
3
Oportunidades
3
Señales de alerta
2
Dirección
10
7 hallazgos más en el informe completo — gratis con cualquier cuenta.
Desbloquea el análisis completo de Johnson & Johnson
Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.
- 3 riesgos, 3 oportunidades y 2 señales de alerta — cada uno con su fuente
- Más de 100 métricas financieras con gráficos y comparativas
- Resúmenes completos de noticias con enlaces a las fuentes
- Equipo directivo y remuneración
- Exportación a PDF para leer sin conexión
III · Empresas similares
También te puede interesar
Mismo sector · Salud — o salud financiera comparable
¿La añades a tu lista?